Lederer & Associates Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$366K Hold
305
0.24% 79
2026
Q1
$281K Hold
305
0.2% 80
2025
Q4
$328K Sell
305
-56
-16% -$53.5K 0.22% 80
2025
Q3
$275K Sell
361
-2,394
-87% -$1.78M 0.18% 82
2025
Q2
$2.15M Buy
2,755
+217
+9% +$169K 1.42% 17
2025
Q1
$2.1M Buy
2,538
+88
+4% +$73.2K 1.53% 19
2024
Q4
$1.89M Buy
2,450
+2,145
+703% +$1.78M 1.32% 17
2024
Q3
$270K Hold
305
0.19% 80
2024
Q2
$276K Hold
305
0.2% 80
2024
Q1
$237K Buy
+305
New +$217K 0.16% 87
2021
Q2
Sell
-305
Closed -$57K 121
2021
Q1
$57K Buy
+305
New +$59.7K 0.04% 102

Other funds holding LLY

Lederer & Associates Investment Counsel's LLY Position: Q2 2026 in Review

Lederer & Associates Investment Counsel held its Eli Lilly (LLY) position steady in Q2 2026 at 305 shares worth $366K. The position accounts for 0.24% of the portfolio, ranked #79.

Lederer & Associates Investment Counsel first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.15M in Q2 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lederer & Associates Investment Counsel held 305 shares of Eli Lilly worth $366K as of Q2 2026.
  • Lederer & Associates Investment Counsel left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.24% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #79 holding.
  • Lederer & Associates Investment Counsel first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
  • Lederer & Associates Investment Counsel's Eli Lilly position peaked at $2.15M in Q2 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.